News Release

Myriad Genetics Announces Second Quarter Fiscal 2008 Financial Results Conference Call

Myriad Genetics Announces Second Quarter Fiscal 2008 Financial Results Conference CallSalt Lake City, UT, Jan 22, 2008—Myriad Genetics, Inc. (NASDAQ: MYGN) has arranged a conference call with the management team to provide a company update. Peter D. Meldrum, President and Chief Executive Officer, will host the call along with Jim Evans, Chief Financial Officer; Gregory C. Critchfield, M.D., President of Myriad Genetic Laboratories, Inc.; and Adrian N. Hobden, Ph.D., President of Myriad Pharmaceuticals, Inc.

DATE: February 5, 2008
TIME: 10:00 am ET
DOMESTIC DIAL-IN: (888) 589-2820
INTERNATIONAL DIAL-IN: (706) 634-2173
CONFERENCE ID# 32258334
(Please dial in approximately 10 minutes before the call is scheduled to begin)

A press release will be issued at 6:30 am ET.

Replay of the call will be available from two hours after the call for seven days by dialing (800) 642-1687 or (706) 645-9291, and entering the conference ID number.

A live audio Webcast will be available at: www.myriad.com.